https://www.selleckchem.com/products/gossypol.html
Weight loss maintenance (WLM) is critical for sustaining type 2 diabetes (T2D) remission, but poorly evidenced. We evaluated brief return to formula low-energy-diet (LED) as relapse treatments (RTs) during the WLM phase of the Diabetes Remission Clinical Trial (DiRECT). This post-hoc evaluation included all participants commencing the WLM phase of DiRECT. The protocol offered RT when regain of 2kg occurred. In total, 123/149 (83%) DiRECT intervention participants commenced the WLM phase after 26 (17%) had withdrawn prior to the WLM
Like
Comment
Share
